AVR 0.65% $18.23 anteris technologies ltd

Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-330

  1. 1,142 Posts.
    lightbulb Created with Sketch. 1
    So what's your plan Lex? Sell out? Or wait until EOFY?
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.